Peter Norman

Biography

Peter Norman leads the U.S. Government Affairs and Policy function for the company, which includes federal and state initiatives as well as programs with professional and patient organizations. Prior to joining Alkermes in 2013, Mr. Norman was the head of the Washington, D.C. office for Eisai, Inc. In addition, he’s held senior positions for Amylin Pharmaceuticals, Inc., Millennium Pharmaceuticals, Inc., Novo Nordisk and the Biotechnology Industry Organization (BIO).

Research Interest

Mr. Norman worked on public policy and regulatory strategies not only for Alzheimer’s disease, obesity and diabetes pharmaceutical products, but also healthcare reform and reimbursement issues.